U.S. flag

An official website of the United States government

NM_001080510.5(METTL23):c.169_172del (p.His57fs) AND Intellectual disability, autosomal recessive 44

Germline classification:
Pathogenic (6 submissions)
Last evaluated:
Feb 2, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000133532.12

Allele description [Variation Report for NM_001080510.5(METTL23):c.169_172del (p.His57fs)]

NM_001080510.5(METTL23):c.169_172del (p.His57fs)

Gene:
METTL23:methyltransferase 23, arginine [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q25.1
Genomic location:
Preferred name:
NM_001080510.5(METTL23):c.169_172del (p.His57fs)
HGVS:
  • NC_000017.11:g.76733062_76733065del
  • NG_032905.1:g.9349_9352del
  • NG_041790.1:g.11233_11236del
  • NM_001080510.5:c.169_172delMANE SELECT
  • NM_001206983.3:c.169_172del
  • NM_001206984.3:c.169_172del
  • NM_001206985.3:c.-33_-30del
  • NM_001206986.3:c.-33_-30del
  • NM_001206987.3:c.-33_-30del
  • NM_001302703.2:c.169_172del
  • NM_001302704.2:c.-33_-30del
  • NM_001302705.2:c.157_160del
  • NM_001378348.1:c.169_172del
  • NM_001378349.1:c.169_172del
  • NM_001378350.1:c.157_160del
  • NM_001378351.1:c.157_160del
  • NM_001378352.1:c.157_160del
  • NM_001378353.1:c.157_160del
  • NM_001378354.1:c.-33_-30del
  • NP_001073979.3:p.His57fs
  • NP_001193912.1:p.His57fs
  • NP_001193912.1:p.His57fs
  • NP_001193913.1:p.His57fs
  • NP_001289632.1:p.His57fs
  • NP_001289634.1:p.His53fs
  • NP_001365277.1:p.His57fs
  • NP_001365278.1:p.His57fs
  • NP_001365279.1:p.His53fs
  • NP_001365280.1:p.His53fs
  • NP_001365281.1:p.His53fs
  • NP_001365282.1:p.His53fs
  • LRG_640:g.9349_9352del
  • NC_000017.10:g.74729144_74729147del
  • NM_001080510.3:c.169_172del
  • NM_001080510.4:c.169_172del
  • NM_001080510.4:c.169_172delCACT
  • NM_001206983.1:c.169_172delCACT
  • NM_001206983.2:c.169_172del
Protein change:
H53fs
Links:
OMIM: 615262.0001; dbSNP: rs587777644
NCBI 1000 Genomes Browser:
rs587777644
Molecular consequence:
  • NM_001206985.3:c.-33_-30del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001206986.3:c.-33_-30del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001206987.3:c.-33_-30del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001302704.2:c.-33_-30del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001378354.1:c.-33_-30del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001080510.5:c.169_172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001206983.3:c.169_172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001206984.3:c.169_172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001302703.2:c.169_172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001302705.2:c.157_160del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001378348.1:c.169_172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001378349.1:c.169_172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001378350.1:c.157_160del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001378351.1:c.157_160del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001378352.1:c.157_160del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001378353.1:c.157_160del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Intellectual disability, autosomal recessive 44 (MRT44)
Synonyms:
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44
Identifiers:
MONDO: MONDO:0014409; MedGen: C4014745; Orphanet: 88616; OMIM: 615942

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000188607OMIM
no assertion criteria provided
Pathogenic
(Jul 1, 2014)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001426514Centogene AG - the Rare Disease Company
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001761083New York Genome Center - CSER-NYCKidSeq
criteria provided, single submitter

(NYGC Assertion Criteria 2020)
Pathogenic
(Jul 3, 2020)
inheritedclinical testing

Citation Link,

SCV002024342Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 7, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002766723Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 2, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004697659Molecular Genetics Lab, CHRU Brest
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicinheritedclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedinheritedyesnot providednot providednot providednot providednot providedclinical testing
not providedinheritedunknown1not providednot provided1not providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.

Bertoli-Avella AM, Beetz C, Ameziane N, Rocha ME, Guatibonza P, Pereira C, Calvo M, Herrera-Ordonez N, Segura-Castel M, Diego-Alvarez D, Zawada M, Kandaswamy KK, Werber M, Paknia O, Zielske S, Ugrinovski D, Warnack G, Kampe K, Iurașcu MI, Cozma C, Vogel F, Alhashem A, et al.

Eur J Hum Genet. 2021 Jan;29(1):141-153. doi: 10.1038/s41431-020-00713-9. Epub 2020 Aug 28.

PubMed [citation]
PMID:
32860008
PMCID:
PMC7852664

METTL23, a transcriptional partner of GABPA, is essential for human cognition.

Reiff RE, Ali BR, Baron B, Yu TW, Ben-Salem S, Coulter ME, Schubert CR, Hill RS, Akawi NA, Al-Younes B, Kaya N, Evrony GD, Al-Saffar M, Felie JM, Partlow JN, Sunu CM, Schembri-Wismayer P, Alkuraya FS, Meyer BF, Walsh CA, Al-Gazali L, Mochida GH.

Hum Mol Genet. 2014 Jul 1;23(13):3456-66. doi: 10.1093/hmg/ddu054. Epub 2014 Feb 5.

PubMed [citation]
PMID:
24501276
PMCID:
PMC4049305
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000188607.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 7 affected members of a consanguineous Yemeni kindred with autosomal recessive intellectual developmental disorder-44 (MRT44; 615942), Reiff et al. (2014) identified a homozygous 4-bp deletion (c.169_172delCACT), in the METTL23 gene, resulting in a frameshift and premature termination (His57ValfsTer11). The mutation, which was found by homozygosity mapping and exome sequencing of the candidate region, was confirmed by Sanger sequencing and segregated with the disorder in the family. The variant was found at a low frequency (1 in 11,615) in the Exome Variant Server database, and a nearby 2-bp deletion (c.171_172delCT) was also present at a low frequency (2 in 11,622). The 4-bp deletion was not present in the 1000 Genomes Project database, in over 800 in-house exomes, or in 357 Saudi exomes. The identified mutation falls within a coding region of the highly conserved isoform 1 of METTL23, and in the 5-prime untranslated region of isoform 2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Centogene AG - the Rare Disease Company, SCV001426514.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From New York Genome Center - CSER-NYCKidSeq, SCV001761083.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedunknown1not providednot provided1not providednot providednot provided

From Revvity Omics, Revvity, SCV002024342.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002766723.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with METTL23-related intellectual disability (MIM#615942). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (26 heterozygotes, 0 homozygotes). (SP) 0702 - Other NMD-predicted variants comparable to the one identified in this case have strong previous evidence for pathogenicity. These variants have been classified as pathogenic, and observed in individuals with METTL23-related intellectual disability (ClinVar, LOVD, PMID: 24626631). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported multiple times as pathogenic, and observed in a family with intellectual disability (ClinVar, PMID: 24501276). (SP) 0901 - This variant has strong evidence for segregation with disease. This variant has segregated in seven homozygous individuals within a single family (PMID: 24501276). (SP) 1102 - Strong phenotype match for this individual. (SP) 1206 - This variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics Lab, CHRU Brest, SCV004697659.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2024